News|Articles|June 10, 2026
FDA Action Update, May 2026: Approvals, Priority Review, and Extension of Review
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology headlines you may have missed in May 2026, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in May 2026, making a number of decisions on potential new therapeutic agents, including accepting a resubmission, granting a clearance, and issuing a complete response letter.
Advertisement
Advertisement